|
|
|
|
pmid:28330896
|
|
|
|
|
pmid:27401285
|
|
|
|
|
pmid:
|
Ichida F et al. |
Chronic effects of oral prostacyclin analogue on thromboxane A2 and prostacyclin metabolites in pulmonary hypertension. |
1998 |
Acta Paediatr Jpn |
pmid:9583194
|
Short BL et al. |
Thromboxane synthetase inhibitors in septic shock. |
1983 |
Adv Shock Res |
pmid:6683924
|
Flynn JT |
Effect of lidocaine on hepatic prostanoid production in vitro following 2,4-dinitrophenol administration. |
1983 |
Adv Shock Res |
pmid:6349294
|
Harada N et al. |
Gastric prostacyclin (PGI2) prevents stress-induced gastric mucosal injury in rats by inhibiting leukocyte activation. |
1997 |
Adv. Exp. Med. Biol. |
pmid:9561161
|
Ryan US and Ryan JW |
Kinins, endothelial cells and calmodulin. |
1983 |
Adv. Exp. Med. Biol. |
pmid:6858759
|
Tanaka H et al. |
Leukotriene (LT)-receptor antagonist is more effective in asthmatic patients with a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin (PG)F1alpha. |
1999 |
Allergy |
pmid:10380781
|
Roy L et al. |
Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol. |
1983 |
Am. J. Cardiol. |
pmid:6823861
|